Body Central Down 33% Pre-Market After Cutting Guidance

Loading...
Loading...
Body Central Corp
BODY
is trading lower pre-market after the company lowered its Q2 and full year guidance. The company now sees Q2 EPS of $0.19 to $0.21 vs $0.27 estimates and FY EPS of $1.07 to $1.11 vs $1.35 estimates. Allen Weinstein, Body Central's President and CEO, stated: "Our second quarter comparable sales remain soft and have not improved since April. We continue to diligently manage inventory and to take aggressive markdowns on slow moving items. As a result, we now expect second quarter sales and gross margin to be lower than contemplated in our May 3rd release." Body Central is currently trading at $10.75, down $5.24 or 32.77% pre-market.
Posted In: Pre-Market OutlookMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...